Edwards Lifesciences (EW) Net Cash Flow Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.71 Bn | 194.11 Bn | 7.27 Bn | -562.77% |
| 2 | Stryker | 127.04 Bn | 123.56 Bn | 4.50 Bn | 2,827.78% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | -395.56% |
| 5 | Edwards Lifesciences | 52.03 Bn | 47.78 Bn | 1.35 Bn | 168.38% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -103.49% |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.67 Bn | 2.18 Bn | -114.85% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -215.59% |
| 9 | Steris | 23.03 Bn | 22.54 Bn | 684.20 Mn | -54.17% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 98.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168.38% |
| Mar 31, 2026 | -564.44% |
| Dec 31, 2025 | 135.70% |
| Sep 30, 2025 | -128.61% |
| Jun 30, 2025 | -57.27% |
| Mar 31, 2025 | 51.05% |
| Dec 31, 2024 | -157.37% |
| Sep 30, 2024 | 481.41% |
| Jun 30, 2024 | 156.38% |
| Mar 31, 2024 | -33.98% |
| Dec 31, 2023 | 43.05% |
| Sep 30, 2023 | 827.79% |
| Jun 30, 2023 | 1.43% |
| Mar 31, 2023 | -30.19% |
| Dec 31, 2022 | 29.56% |
| Sep 30, 2022 | -80.10% |
| Jun 30, 2022 | 11.70% |
| Mar 31, 2022 | 758.30% |
| Dec 31, 2021 | -460.89% |
| Sep 30, 2021 | 56.30% |